Global Bifidobacterium Probiotic Market - 2024-2031

Overview

Global Bifidobacterium Probiotic Market reached US$ 1.1 billion in 2023 and is expected to reach US$ 1.9 billion by 2031, growing with a CAGR of 8.8% during the forecast period 2024-2031.

There is increasing awareness among consumers about the importance of gut health and the role of probiotics, including bifidobacterium, in maintaining it. This heightened awareness is driving demand for probiotic products across various demographics, fueling market growth. Manufacturers are diversifying their product offerings to cater to different consumer preferences and needs, providing consumers with more options to incorporate probiotics into their daily routines.

For instance, on May 23, 2023, PanTheryx's probiotic supplements brand, TruBiotics, introduced two new supplements tailored to address various aspects of women's health. The formulation of these capsules includes a combination of probiotic strains known for their efficacy in promoting digestive and vaginal health. Among these strains is Bifidobacterium animalis, recognized as one of the most extensively researched beneficial bacteria for digestive well-being.

As consumers become more health-conscious, there is a growing interest in probiotic products, including bifidobacterium probiotics, to support digestive health and overall well-being in the Asia-Pacific. Companies in the Asia-Pacific region are investing in research and development to explore the health benefits of probiotics and develop innovative products. This includes studying the efficacy of bifidobacterium probiotics in addressing specific health conditions prevalent in the region.

Dynamics

Increasing Consumer Awareness About Gut Health

As more people recognize the importance of maintaining a healthy gut microbiome for overall well-being, there is a growing demand for probiotic supplements and foods that contain bifidobacterium. This heightened awareness is prompting consumers to seek out products that can improve digestive health, boost immunity, and enhance overall wellness, thus expanding the market.

Marketing efforts by companies to educate consumers about the benefits of bifidobacterium probiotics are also playing a crucial role. By highlighting the positive effects on gut health, these campaigns are attracting a larger customer base. As a result, the global bifidobacterium probiotic market is experiencing significant growth, driven by an informed and health-conscious consumer population.

For instance, on October 10, 2023, A Guangdong-based company, known for its expertise in producing popping candy as a staple food item, innovated its product line by incorporating functional ingredients to enhance nutritional value. The company has introduced a new range of candy infused with vitamin C and probiotics, specifically Bifidobacterium in the competitive market.

Traditionally recognized for its popping candy offerings, the company is leveraging its manufacturing techniques to create a novel candy experience enriched with health-promoting ingredients. By incorporating vitamin C and Bifidobacterium probiotics into the candy formulation, the company aims to provide consumers with a convenient and enjoyable way to boost their immune system and support digestive health.

Growing Preference for Natural and Organic Products

The growing preference for natural and organic products is a major factor driving the global bifidobacterium probiotic market. As consumers increasingly seek healthier and more sustainable options, they are turning to natural and organic probiotics to enhance their gut health. This trend is particularly strong among health-conscious individuals who prefer products free from synthetic additives and preservatives.

In response to this demand, manufacturers in the market are focusing on developing bifidobacterium probiotics that align with natural and organic standards. This shift is not only attracting a broader customer base but also encouraging innovation and product diversification within the market. Consequently, the preference for natural and organic products is significantly contributing to the expansion and growth of the global bifidobacterium probiotic market.

For instance, on April 28, 2022, China's dairy powerhouse, Yili, launched its latest product launch strategies, focusing on the introduction of innovative offerings to meet evolving consumer preferences. Among these strategies is the debut of a solid beverage enriched with probiotics and GABA as its primary ingredients. While Yili has established a strong presence in the dairy market, particularly with probiotic-infused products like yogurt, cheese, and ice cream, this new venture into solid beverages marks a strategic expansion of its product portfolio.

Stringent Regulatory Frameworks

Stringent regulatory frameworks are a significant restraint on the global bifidobacterium probiotic market. Regulatory bodies across different regions impose strict guidelines on the approval, labeling, and marketing of probiotic products to ensure safety and efficacy. These regulations often require extensive clinical trials and scientific evidence to substantiate health claims, which can be costly and time-consuming for manufacturers.

As a result, smaller companies face barriers to entry, and even established players in the market might experience delays in product launches and additional compliance costs. This regulatory burden can limit the speed at which new bifidobacterium probiotic products are brought to market and can also reduce the variety of products available to consumers. Stringent regulatory frameworks act as a significant constraint, impacting the growth and expansion of the global bifidobacterium probiotic market.

For instance, on December 27, 2023, The regulatory agency recently received a concerning adverse event report concerning a preterm infant who received treatment with the probiotic Evivo with MCT Oil (Infinant Health) as part of in-hospital care to prevent necrotizing enterocolitis. Tragically, following the administration of Evivo, the patient developed sepsis, attributed to the bacterium Bifidobacterium longum present in Evivo, and subsequently succumbed. This incident is among several reported cases where preterm infants experienced adverse events after receiving probiotics marketed as preventive measures against the disease.

Segment Analysis

The global bifidobacterium probiotic market is segmented based on type, form, application, end-user, and region.

Growing Innovations and Consumer Preference for Bifidobacterium longum

Consumers are increasingly seeking out probiotic products containing specific strains like Bifidobacterium longum due to their perceived health benefits and efficacy. This consumer preference drives demand for products containing this strain, contributing to its dominant position in the market. Bifidobacterium longum is commonly used in a variety of probiotic products. Its versatility and proven efficacy make it an attractive option for manufacturers looking to develop probiotic formulations to meet diverse consumer needs.

Bifidobacterium longum is one of the most extensively studied probiotic strains, with numerous clinical studies supporting its efficacy in promoting gut health and overall well-being. This robust scientific evidence enhances consumer confidence in the effectiveness of products containing Bifidobacterium longum, driving market demand. Companies often highlight the inclusion of Bifidobacterium longum in their products as a key selling point, leveraging its well-established reputation and positive consumer perception to drive sales and capture market share.

Geographical Penetration

Strong Tradition of Fermented Foods and Investments in Asia-Pacific

The Asia-Pacific region has a significant portion of the world's population, including densely populated countries like China and India. Many countries in the Asia-Pacific region have a long tradition of consuming fermented foods like yogurt, kimchi, and miso, which naturally contain probiotics. This cultural familiarity with probiotic-rich foods contributes to the growing acceptance and demand for bifidobacterium probiotics in the region.

Governments, academic institutions, and private companies in the Asia-Pacific region are investing heavily in research and development to explore the health benefits of probiotics and develop innovative products. This focus on innovation and product development is driving market growth and strengthening the region's position in the global bifidobacterium probiotic market.

COVID-19 Impact Analysis

The COVID-19 pandemic had a notable impact on the global bifidobacterium probiotic market. During the pandemic, there was a heightened focus on health and wellness, leading to increased consumer interest in products that support immune function and overall health, including bifidobacterium probiotics. This surge in demand positively influenced the market, as more individuals sought probiotics to boost their immunity and maintain gut health during a time of increased health awareness.

However, the market also faced challenges due to COVID-19. Supply chain disruptions and logistical issues caused delays in the production and distribution of probiotic products. Additionally, economic uncertainties led to cautious consumer spending, affecting the market's growth rate. Despite these challenges, the overall impact of COVID-19 has been a renewed emphasis on preventive health measures, which is likely to sustain the market's growth in the long term as consumers continue to prioritize their health post-pandemic.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine war has indirect effects on the global bifidobacterium probiotic market due to potential disruptions in the supply chain and geopolitical instability. Ukraine is a significant producer of grains, including wheat, which is a key ingredient in animal feed. Bifidobacterium probiotics are commonly used in animal feed to promote gut health and improve overall livestock health.

Disruptions in the Ukrainian grain market could lead to fluctuations in feed prices, affecting the livestock industry worldwide. This, in turn, may impact the demand for bifidobacterium probiotics, as farmers adjust their purchasing decisions based on feed costs. Geopolitical tensions and economic sanctions imposed on Russia and Ukraine could disrupt trade routes and distribution channels for bifidobacterium probiotic products.

By Type

• Bifidobacterium animalis
• Bifidobacterium longum
• Bifidobacterium bifidum
• Others

By Form

• Dry
• Liquid

By Application

• Food & Beverages
• Dietary Supplements
• Pharmaceuticals
• Animal Feed
• Others

By End-User

• Infants
• Adults
• Children
• Animals

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Key Developments

• On January 30, 2023, Nissin Foods Group, announced the launch of Foods with Function Claims (FFCs) featuring lactic acid bacteria for the first time. This innovative move reflects the company's commitment to staying at the forefront of evolving consumer preferences and trends, particularly in the realm of gut health and the gut-brain axis.
• On March 1, 2021, Bayer expanded its portfolio beyond gastrointestinal relief to address overall gut health with the introduction of two new probiotic products. Developed in collaboration with China's Jiangnan University, these probiotics are specifically formulated to target common gastrointestinal issues, including constipation and diarrhea.
• On June 16, 2020, Yakult Japan introduced its inaugural shelf-stable probiotic supplement, marking a significant expansion in its product offerings. Packed into convenient sachets, this supplement contains two exclusive probiotic strains: the renowned lactic acid bacteria, Lactobacillus casei strain Shirota, and the beneficial bifidobacteria, Bifidobacterium breve strain Yakult.

Competitive Landscape

The major players in the global bifidobacterium probiotic market include DuPont, Goerlich Pharma GmbH, Mitushi Bio Pharma, and Chr. Hansen Holding A/S, Probi AB, Lallemand Inc., Novozymes A/S, Danone Corp, Nestle S.A., Yakult Honsha Co., Ltd.

Why Purchase the Report?

• To visualize the global bifidobacterium probiotic market segmentation based on type, form, application, end-user, and region and understand critical commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous global streptococcus probiotic market-level data points with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of critical products of all the major players.

The global bifidobacterium probiotic market report would provide approximately 70 tables, 65 figures, and 213 users.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies